Focused ultrasound for enlarged prostate symptoms
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a non-invasive treatment using high-intensity focused ultrasound (HIFU) to reduce prostate tissue that blocks urine flow. It may help men with moderate to severe urinary symptoms from an enlarged prostate who haven't had success with or can't take medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 45 and 80 years old.
- You have moderate to severe trouble urinating (score of 12 or higher on a symptom questionnaire).
- Your prostate is between 30 and 80 cubic centimeters (about the size of a walnut to a small lemon).
- You have tried or cannot take medication for urination problems.
- You are willing to sign a consent form and follow the study schedule.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a newer, minimally invasive treatment (high-frequency irreversible electroporation) against standard treatments for an enlarged prostate causing urinary symptoms. The goal is to see if this approach relieves symptoms with fewer side effects.
This study collects data on men with early, low-risk prostate cancer who choose to have a targeted ultrasound treatment called HIFU (High-Intensity Focused Ultrasound). It looks at how well this treatment works and how men recover.
This trial uses a special PET/MRI scan to check if prostate cancer has come back after high-intensity focused ultrasound (HIFU) treatment. It aims to find any remaining cancer early so doctors can plan next steps.
This trial tests a focused ultrasound treatment for benign prostatic hyperplasia (BPH), which is a non-cancerous enlargement of the prostate. It aims to see if HIFU can safely relieve symptoms like weak urine flow and frequent urination.
This trial studies whether a high-intensity focused ultrasound treatment can help people with localized prostate cancer while still avoiding traditional full-dose treatment for some patients. It may be an option for certain intermediate-risk cases where the cancer is confined to the prostate.
This trial studies a focused ultrasound treatment called HIFU for prostate cancer that appears limited to the early stages. It aims to treat cancer within the prostate while avoiding treatment spread to lymph nodes or distant organs.
Hear when a new Bladder Outlet Obstruction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.